[
    [
        {
            "time": "2020-12-10",
            "original_text": "凯莱英(002821.SZ)拟投500万美元于美国设立创新药CDMO研发中心",
            "features": {
                "keywords": [
                    "凯莱英",
                    "CDMO",
                    "研发中心",
                    "美国",
                    "投资"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "凯莱英(002821.SZ)拟投500万美元于美国设立创新药CDMO研发中心",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-12-10",
            "original_text": "高瓴资本概念股再度活跃，泰格医药、国瓷材料、甘李药业等普涨",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "概念股",
                    "泰格医药",
                    "国瓷材料",
                    "甘李药业",
                    "普涨"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "高瓴资本概念股再度活跃，泰格医药、国瓷材料、甘李药业等普涨",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-01-01",
            "original_text": "2021年度策略行业策略：医药黄金时代行情不会缺席 2021只是更加极致聚焦",
            "features": {
                "keywords": [
                    "2021年度策略",
                    "医药",
                    "黄金时代",
                    "聚焦"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "2021年度策略行业策略：医药黄金时代行情不会缺席 2021只是更加极致聚焦",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 3,
                "Headline_Structure": 9,
                "Source_Recency": 2
            }
        }
    ]
]